Form 8-K - Current report:
SEC Accession No. 0001104659-25-044999
Filing Date
2025-05-06
Accepted
2025-05-06 14:59:18
Documents
14
Period of Report
2025-05-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514119d2_8k.htm   iXBRL 8-K 29134
2 EXHIBIT 99.1 tm2514119d2_ex99-1.htm EX-99.1 24081
  Complete submission text file 0001104659-25-044999.txt   233390

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20250506.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20250506_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20250506_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2514119d2_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 25916765
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)